GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Vaccines, MDPI AG, Vol. 9, No. 6 ( 2021-06-12), p. 643-
    Abstract: Background: This study evaluates the possible effect of 9-valent (9vHPV) vaccination on the results of HPV and cytological tests in a cohort of adult women. Methods: This study is a retrospective, single-cohort, monocentric study. Sexually active women aged 14–70 years, who underwent 9vHPV vaccination, were enrolled. Dose administration dates, side effects and data on Pap smears and HPV tests performed before and after the first vaccine dose were collected. Subjects were considered “unexposed” to the vaccine for all time intervals before the first dose administration, and “exposed” to the first, second and third vaccine doses in all time intervals following each specific dose. Results: A total of 512 women underwent the first 9vHPV dose administration and were enrolled in the study. Median age at vaccination was 30.5 (14–70). Log-rank tests and Cox regression analyses showed a highly statistically significant (p 〈 0.0001) difference in the time to negativization after the exposure to the third vaccine dose in the 207 women starting with a Pap+ smear (HR (95% C.I.), 2.66 (1.83–3.86)) and in the 198 women starting with an HPV HR+ test (HR (95% C.I.), 7.80 (4.83–12.60)). Conclusions: 9vHPV vaccination may play a role in shortening the clearance time of HPV HR+ or Pap positivity in sexually active adult women.
    Type of Medium: Online Resource
    ISSN: 2076-393X
    Language: English
    Publisher: MDPI AG
    Publication Date: 2021
    detail.hit.zdb_id: 2703319-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    Wiley ; 2016
    In:  United European Gastroenterology Journal Vol. 4, No. 2 ( 2016-04), p. 297-304
    In: United European Gastroenterology Journal, Wiley, Vol. 4, No. 2 ( 2016-04), p. 297-304
    Abstract: Acute abdominal pain (AAP) is one of the most common causes of referral to an emergency department (ED), but information about its impact is limited. Objectives The objectives of this article are to define the prevalence of AAP among ED visits in a large university hospital and analyze its main clinical features. Methods All patients admitted at the Sant’Orsola, Malpighi University Hospital of Bologna ED on 12 a priori selected sample days in 2013 were included. General data were recorded for each patient. A total of 192 clinical variables were recorded for each patient with abdominal pain. Results During the observation period the ED assisted 2623 patients with a daily admission rate of 219 ± 20 (mean ± SD). Of these, 239 patients complained of AAP as their chief complaint at entry (prevalence = 9.1%). AAP prevalence was significantly higher in females than in males (10.4% vs. 7.8%; OR = 1.37; p  = 0.021) as well as in foreign over Italian patients (13.2% vs. 8.5%; OR = 1.64; p  = 0.007). The most frequent ED operative diagnoses were non‐specific abdominal pain ( n  = 86, 36.0%) and gastrointestinal (GI) tract‐related pain ( n  = 79, 33.1%; n  = 19 upper GI, n  = 60 lower GI). Conclusions AAP is a common cause of referral at EDs. Despite technological advances, non‐specific abdominal pain is still the main operative diagnosis.
    Type of Medium: Online Resource
    ISSN: 2050-6406 , 2050-6414
    Language: English
    Publisher: Wiley
    Publication Date: 2016
    detail.hit.zdb_id: 2728585-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: Stem Cell Reports, Elsevier BV, Vol. 13, No. 5 ( 2019-11), p. 847-861
    Type of Medium: Online Resource
    ISSN: 2213-6711
    Language: English
    Publisher: Elsevier BV
    Publication Date: 2019
    detail.hit.zdb_id: 2720528-9
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    In: Molecular Autism, Springer Science and Business Media LLC, Vol. 11, No. 1 ( 2020-12)
    Abstract: Patients diagnosed with chromosome microdeletions or duplications, known as copy number variants (CNVs), present a unique opportunity to investigate the relationship between patient genotype and cell phenotype. CNVs have high genetic penetrance and give a good correlation between gene locus and patient clinical phenotype. This is especially effective for the study of patients with neurodevelopmental disorders (NDD), including those falling within the autism spectrum disorders (ASD). A key question is whether this correlation between genetics and clinical presentation at the level of the patient can be translated to the cell phenotypes arising from the neurodevelopment of patient induced pluripotent stem cells (iPSCs). Here, we examine how iPSCs derived from ASD patients with an associated CNV inform our understanding of the genetic and biological mechanisms underlying the aetiology of ASD. We consider selection of genetically characterised patient iPSCs; use of appropriate control lines; aspects of human neurocellular biology that can capture in vitro the patient clinical phenotype; and current limitations of patient iPSC-based studies. Finally, we consider how future research may be enhanced to maximise the utility of CNV patients for research of pathological mechanisms or therapeutic targets.
    Type of Medium: Online Resource
    ISSN: 2040-2392
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2020
    detail.hit.zdb_id: 2540930-X
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    In: Nature, Springer Science and Business Media LLC, Vol. 587, No. 7834 ( 2020-11-19), p. 377-386
    Type of Medium: Online Resource
    ISSN: 0028-0836 , 1476-4687
    RVK:
    RVK:
    RVK:
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2020
    detail.hit.zdb_id: 120714-3
    detail.hit.zdb_id: 1413423-8
    SSG: 11
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    Online Resource
    Online Resource
    EMBO ; 2021
    In:  The EMBO Journal Vol. 40, No. 2 ( 2021-01-15)
    In: The EMBO Journal, EMBO, Vol. 40, No. 2 ( 2021-01-15)
    Type of Medium: Online Resource
    ISSN: 0261-4189 , 1460-2075
    RVK:
    Language: English
    Publisher: EMBO
    Publication Date: 2021
    detail.hit.zdb_id: 1467419-1
    detail.hit.zdb_id: 586044-1
    SSG: 12
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    In: Science, American Association for the Advancement of Science (AAAS), Vol. 375, No. 6582 ( 2022-02-18)
    Abstract: Endocrine disrupting chemicals (EDCs) are compounds that interfere with physiological hormonal regulation. Humans are pervasively exposed to many different EDCs, and a growing body of evidence indicates that early life exposure to such EDC mixtures can induce changes in the human organism that underlie increased susceptibility to diseases throughout the life span, including neurodevelopmental disorders. Chemical regulation is, however, entirely based on the risk assessment of individual compounds, leaving the real-life impact of chemical mixtures unexamined and unregulated. This is relevant insofar as cumulative exposure to multiple compounds may be associated with adverse health outcomes even when the concentrations of individual chemicals fall below the regulatory dose. RATIONALE We set out to make the epidemiological associations between exposure to mixtures and health outcomes experimentally tractable, defining molecular pathways and dose responses that could be translated back to actual human exposures and thereby refine current risk assessment practices. As opposed to previous studies that focused on single compounds, we identified and tested an EDC mixture associated with adverse neurodevelopmental outcomes in the Swedish Environmental Longitudinal, Mother and child, Asthma and allergy (SELMA) pregnancy cohort (MIX N) by integrating epidemiological data with experimental toxicology and characterized real life–relevant exposure. RESULTS We used weighted quantile sum (WQS) regression to identify chemicals associated with language delay in children and included those chemicals in MIX N. MIX N was synthesized following the relative proportions and total concentrations found in the SELMA cohort. It was then tested in both in vitro and in vivo models. In human fetal primary neural stem cells and three-dimensional cortical brain organoids differentiated from human pluripotent stem cells, transcriptomic analysis showed that MIX N interferes with hormonal pathways and dysregulates expression of genes and biological pathways that are causally linked to autism spectrum disorders. Data from experiments in Xenopus leavis and Danio rerio , in vivo models validated by the Organisation for Economic Co-operation and Development (OECD), confirmed thyroid function as one of the key and unifying points of vulnerability to MIX N and linked thyroid disruption to neurodevelopmental effects measured as alterations in locomotor activity. The resulting dose-response relationships were then used to estimate a point of departure (POD), which is the toxicological measure to estimate no-effect concentration. This enabled us to apply a similar mixture approach (SMACH) where we (i) identified individuals in the SELMA study who were sufficiently similarly exposed compared with the experimental mixtures and (ii) determined the proportion of the SELMA children with exposure ranges of concern using the POD as reference. CONCLUSION Integrating experimental and epidemiological evidence, we established mechanistic and correlative evidence for neurodevelopmental adversities of an EDC mixture associated with language delay. Using the generated experimental data in a risk assessment concept, we found increased odds of language delay in offspring of up to 54% of pregnant women. These results emphasize the need to take mixtures into account during chemical testing and risk assessment and provide an integrative framework to guide risk assessment strategies. Diagram showing the integrative framework of the study. A mixture of EDCs was associated with adverse neurodevelopmental outcomes in the SELMA pregnancy cohort and was tested in human in vitro and in in vivo models to elucidate the molecular and functional impact of exposure. Experimental data were finally referred back to the cohort for risk assessment by a similar mixture approach. PFAS, perfluoroalkyl substance.
    Type of Medium: Online Resource
    ISSN: 0036-8075 , 1095-9203
    RVK:
    RVK:
    Language: English
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date: 2022
    detail.hit.zdb_id: 128410-1
    detail.hit.zdb_id: 2066996-3
    detail.hit.zdb_id: 2060783-0
    SSG: 11
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 8
    Online Resource
    Online Resource
    Springer Science and Business Media LLC ; 2020
    In:  Molecular Autism Vol. 11, No. 1 ( 2020-12)
    In: Molecular Autism, Springer Science and Business Media LLC, Vol. 11, No. 1 ( 2020-12)
    Abstract: The complex pathophysiology of autism spectrum disorder encompasses interactions between genetic and environmental factors. On the one hand, hundreds of genes, converging at the functional level on selective biological domains such as epigenetic regulation and synaptic function, have been identified to be either causative or risk factors of autism. On the other hand, exposure to chemicals that are widespread in the environment, such as endocrine disruptors, has been associated with adverse effects on human health, including neurodevelopmental disorders. Interestingly, experimental results suggest an overlap in the regulatory pathways perturbed by genetic mutations and environmental factors, depicting convergences and complex interplays between genetic susceptibility and toxic insults. The pervasive nature of chemical exposure poses pivotal challenges for neurotoxicological studies, regulatory agencies, and policy makers. This highlights an emerging need of developing new integrative models, including biomonitoring, epidemiology, experimental, and computational tools, able to capture real-life scenarios encompassing the interaction between chronic exposure to mixture of substances and individuals’ genetic backgrounds. In this review, we address the intertwined roles of genetic lesions and environmental insults. Specifically, we outline the transformative potential of stem cell models, coupled with omics analytical approaches at increasingly single cell resolution, as converging tools to experimentally dissect the pathogenic mechanisms underlying neurodevelopmental disorders, as well as to improve developmental neurotoxicology risk assessment.
    Type of Medium: Online Resource
    ISSN: 2040-2392
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2020
    detail.hit.zdb_id: 2540930-X
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 9
    In: Translational Psychiatry, Springer Science and Business Media LLC, Vol. 12, No. 1 ( 2022-12-20)
    Abstract: Brain organoids are becoming increasingly relevant to dissect the molecular mechanisms underlying psychiatric and neurological conditions. The in vitro recapitulation of key features of human brain development affords the unique opportunity of investigating the developmental antecedents of neuropsychiatric conditions in the context of the actual patients’ genetic backgrounds. Specifically, multiple strategies of brain organoid (BO) differentiation have enabled the investigation of human cerebral corticogenesis in vitro with increasing accuracy. However, the field lacks a systematic investigation of how closely the gene co-expression patterns seen in cultured BO from different protocols match those observed in fetal cortex, a paramount information for ensuring the sensitivity and accuracy of modeling disease trajectories. Here we benchmark BO against fetal corticogenesis by integrating transcriptomes from in-house differentiated cortical BO (CBO), other BO systems, human fetal brain samples processed in-house, and prenatal cortices from the BrainSpan Atlas. We identified co-expression patterns and prioritized hubs of human corticogenesis and CBO differentiation, highlighting both well-preserved and discordant trends across BO protocols. We evaluated the relevance of identified gene modules for neurodevelopmental disorders and psychiatric conditions finding significant enrichment of disease risk genes especially in modules related to neuronal maturation and synapsis development. The longitudinal transcriptomic analysis of CBO revealed a two-step differentiation composed of a fast-evolving phase, corresponding to the appearance of the main cell populations of the cortex, followed by a slow-evolving one characterized by milder transcriptional changes. Finally, we observed heterochronicity of differentiation across BO models compared to fetal cortex. Our approach provides a framework to directly compare the extent of in vivo/in vitro alignment of neurodevelopmentally relevant processes and their attending temporalities, structured as a resource to query for modeling human corticogenesis and the neuropsychiatric outcomes of its alterations.
    Type of Medium: Online Resource
    ISSN: 2158-3188
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2022
    detail.hit.zdb_id: 2609311-X
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...